Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koya, D.
Right arrow Articles by Haneda, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koya, D.
Right arrow Articles by Haneda, M.
J Am Soc Nephrol 14:S250-S253, 2003
© 2003 American Society of Nephrology


Supplement Article

Effects of Antioxidants in Diabetes-Induced Oxidative Stress in the Glomeruli of Diabetic Rats

Daisuke Koya, Kazuyuki Hayashi, Munehiro Kitada, Atsunori Kashiwagi, Ryuichi Kikkawa and Masakazu Haneda

Department of Medicine, Shiga University of Medical Science, Shiga, Japan.

Correspondence to Dr. Masakazu Haneda, Seta, Otsu, Shiga 520-2192, Japan; Phone: 81-775-48-2222; Fax: 81-775-43-3858;

ABSTRACT. Numerous reports have demonstrated that oxidative stress induced by diabetes plays an important role in the development and progression of diabetic vascular complications including nephropathy. Indeed, there is emerging evidence that the formation of reactive oxygen species (ROS) is a direct consequence of hyperglycemia. Biomarkers for oxidative damage to DNA, lipids, and proteins are also supporting the concept of increased oxidative stress in diabetes and diabetic nephropathy. However, there is an unanswered question: When does oxidative stress as a pathogenetic event occur in the process of diabetic nephropathy? To answer this question, glomerular ROS was imaged with the use of 2', 7'-dichlorofluorescein diacetate (DCFH-DA). The image of DCF fluorescence was strong in glomeruli from diabetic rats as compared with that of glomeruli from nondiabetic control rats. mRNA expression of antioxidant enzymes such as catalase, glutathione peroxidase, Cu/Zn superoxide dismutase, and heme oxygenase-1 (HO-1) was also determined because oxidative stress definitely refers to the situation of an imbalance between the production of ROS and antioxidant defense. The mRNA expression of catalase, glutathione peroxidase, and Cu/Zn superoxide dismutase 2 wk after the induction of diabetes was not significantly different from that in control rats. Alternatively, mRNA and protein expression of HO-1 was strongly induced by 16-fold in diabetic glomeruli after the induction of diabetes. Antioxidant treatment with either vitamin E or probucol almost completely normalized HO-1 overexpression in diabetic glomeruli, supporting the existence of oxidative stress in the glomeruli of early diabetes. Furthermore, It has reported that antioxidant treatment with vitamin E, probucol, {alpha}-lipoic acid, or taurine normalized diabetes-induced not only renal dysfunction such as albuminuria and glomerular hypertension but also glomerular pathologies. In summary, oxidative stress by diabetes could play a crucial role in the development and progression of diabetic nephropathy, and antioxidant treatment could be a potential therapeutic procedure for diabetic nephropathy. E-mail: haneda@belle.shiga-med.ac.jp




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. Zheng, E. C. Carlson, L. Yang, P. M. Kralik, Y. Huang, and P. N. Epstein
Podocyte-Specific Overexpression of the Antioxidant Metallothionein Reduces Diabetic Nephropathy
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2077 - 2085.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y. S. Kanwar, J. Wada, L. Sun, P. Xie, E. I. Wallner, S. Chen, S. Chugh, and F. R. Danesh
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Experimental Biology and Medicine, January 1, 2008; 233(1): 4 - 11.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Al-Kateb, A. P. Boright, L. Mirea, X. Xie, R. Sutradhar, A. Mowjoodi, B. Bharaj, M. Liu, J. M. Bucksa, V. L. Arends, et al.
Multiple Superoxide Dismutase 1/Splicing Factor Serine Alanine 15 Variants Are Associated With the Development and Progression of Diabetic Nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics Study
Diabetes, January 1, 2008; 57(1): 218 - 228.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Jun Yuan, Ruhan Jia, and Yan Bao
Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2007; 8(3): 118 - 126.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Guo, Z. Xia, J. Jiang, and J. H. McNeill
Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1728 - H1736.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. V. Shah, R. Baliga, M. Rajapurkar, and V. A. Fonseca
Oxidants in Chronic Kidney Disease
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 16 - 28.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
T. A. McGowan, S. R. Dunn, B. Falkner, and K. Sharma
Stimulation of Urinary TGF-{beta} and Isoprostanes in Response to Hyperglycemia in Humans
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 263 - 268.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. B. de Haan, N. Stefanovic, D. Nikolic-Paterson, L. L. Scurr, K. D. Croft, T. A. Mori, P. Hertzog, I. Kola, R. C. Atkins, and G. H. Tesch
Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy
Am J Physiol Renal Physiol, September 1, 2005; 289(3): F544 - F551.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. G. Rosca, T. G. Mustata, M. T. Kinter, A. M. Ozdemir, T. S. Kern, L. I. Szweda, M. Brownlee, V. M. Monnier, and M. F. Weiss
Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F420 - F430.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Satoh, S. Fujimoto, Y. Haruna, S. Arakawa, H. Horike, N. Komai, T. Sasaki, K. Tsujioka, H. Makino, and N. Kashihara
NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy
Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1144 - F1152.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. Morrison, K. Knoll, M. J. Hessner, and M. Liang
Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response
Physiol Genomics, May 19, 2004; 17(3): 271 - 282.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP